TONGLI PHARMACEUTICALS (USA), INC. — Revenue by Fiscal Year
3 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/bf449bb4-1793-4f08-93fa-3d31bb68f142/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2012 | $11.1M | 2012-04-01 – 2013-03-31 | evidence 0001144204-13-037283 |
| FY 2011 | $15.5M | 2011-04-01 – 2012-03-31 | evidence 0001144204-12-039586 |
| FY 2010 | $14.7M | 2010-04-01 – 2011-03-31 | evidence 0001144204-12-039586 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
TONGLI PHARMACEUTICALS (USA), INC. — all facts · Net Income · Operating Income